Abstract
IDH-mutant gliomas are classified into astrocytic or oligodendroglial tumors by 1p/19q status in the WHO 2016 classification, with the latter presenting with characteristic morphology and better prognosis in general. However, the morphological and genetic features within each category are varied, and there might be distinguishable subtypes. We analyzed 170 WHO grade II-IV gliomas resected in our institution. 1p/19q status was analyzed by microsatellite analysis, and genetic mutations were analyzed by next-generation sequencing and Sanger sequencing. For validation, the Brain Lower Grade Glioma dataset of The Cancer Genome Atlas was analyzed. Of the 42 grade III IDH-mutated gliomas, 12 were 1p-intact/19q-intact (anaplastic astrocytomas [AA]), 7 were 1p-intact/19q-loss (AA), and 23 showed 1p/19q-codeletion (anaplastic oligodendrogliomas). Of the 88 IDH-wild type glioblastomas (GBMs), 14 showed 1p-intact/19q-loss status. All of the seven 1p-intact/19q-loss AAs harbored TP53 mutation, but no TERT promotor mutation. All 19q-loss AAs had regions presenting oligodendroglioma-like morphology, and were associated with significantly longer overall survival compared to 19q-intact AAs (P = .001). This tendency was observed in The Cancer Ge...Continue Reading
References
Oct 17, 1998·Neuropathology and Applied Neurobiology·S B WhartonJ R Anderson
Oct 17, 1998·Journal of the National Cancer Institute·J G CairncrossD N Louis
Nov 15, 2002·Journal of Neuropathology and Experimental Neurology·Arie PerryJohan M Kros
Mar 5, 2004·Brain Pathology·Akitake MukasaHiroyuki Aburatani
May 12, 2004·Neuro-oncology·Daniel J BratUNKNOWN Radiation Therapy Oncology Group
Oct 14, 2005·Acta Neuropathologica·Istvan VajtaiErik Vassella
Oct 19, 2006·Cancer Research·Robert B JenkinsJan C Buckner
Jun 5, 2007·Histopathology·M VybergP S Teglbjaerg
Sep 11, 2008·Journal of Neuro-oncology·Hiroaki TakeuchiKazufumi Sato
Aug 6, 2011·Science·Chetan BettegowdaKenneth W Kinzler
Feb 14, 2012·Neuro-oncology·Yongzhi WangTao Jiang
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentKhê Hoang-Xuan
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory CairncrossMinesh Mehta
Sep 24, 2013·Human Pathology·Takanori HiroseAtsushi Sasaki
Oct 26, 2013·Neuro-oncology·Ross C LaxtonSafa Al-Sarraj
Apr 8, 2015·Nature Genetics·Hiromichi SuzukiSeishi Ogawa
Apr 20, 2016·Nature Communications·Aurélie KamounUNKNOWN POLA network
May 10, 2016·Acta Neuropathologica·David N LouisDavid W Ellison
Oct 30, 2016·Brain Pathology·Franck BielleUNKNOWN Pola Network
Mar 9, 2017·Acta Neuropathologica Communications·Koki AiharaNobuhito Saito
Citations
Nov 7, 2019·International Journal of Cancer. Journal International Du Cancer·Anna P SokolenkoEvgeny N Imyanitov
Jul 10, 2020·Cancers·Kanish Mirchia, Timothy E Richardson
Nov 17, 2020·Frontiers in Neurology·Ziren KongFeng Feng
Jan 13, 2021·Journal of Neuropathology and Experimental Neurology·Yohei MiyakeTetsuya Yamamoto
Nov 25, 2020·Aging·Tingyu LiangEnshan Feng
Jun 19, 2021·Molecular Therapy Oncolytics·Wanzun LinJiade J Lu
Jul 23, 2021·EJNMMI Research·Kenta SuzukiTakashi Tamiya
Jul 31, 2021·Journal of Neuro-oncology·Ryohei OtaniKeisuke Ueki
Aug 31, 2021·Frontiers in Cell and Developmental Biology·Xingang ZhouPeng Wang
Dec 2, 2019·Neurosurgical Focus·Anshit GoyalIan F Parney